Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

ISTA submits IND for phase IIb study of ecabet sodium for dry eye syndrome

March 23, 2005

IND accepted for clinical testing of Moli-1901 for dry eye syndrome

March 18, 2005

Miravant plans confirmatory phase III study for Photrex

March 17, 2005

Avastin shows promise for wet AMD

March 14, 2005

Retaane safe in patients with macular degeneration

March 14, 2005

RNAi therapeutic shows potential for AMD in animal model

March 8, 2005

Positive preliminary phase II data for Evizon in AMD

March 8, 2005

OccuLogix cleared to begin crossover studies of RHEO system for dry AMD

March 3, 2005

First patient treated in phase I advanced AMD study of Litx

March 1, 2005

GenVec expands testing of AdPEDF for AMD

Feb. 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...